Literature DB >> 30554722

A Pediatric Asthma Risk Score to better predict asthma development in young children.

Jocelyn M Biagini Myers1, Eric Schauberger2, Hua He3, Lisa J Martin4, John Kroner5, Gregory M Hill5, Patrick H Ryan6, Grace K LeMasters7, David I Bernstein8, James E Lockey7, S Hasan Arshad9, Ramesh Kurukulaaratchy9, Gurjit K Khurana Hershey10.   

Abstract

BACKGROUND: Asthma phenotypes are currently not amenable to primary prevention or early intervention because their natural history cannot be reliably predicted. Clinicians remain reliant on poorly predictive asthma outcome tools because of a lack of better alternatives.
OBJECTIVE: We sought to develop a quantitative personalized tool to predict asthma development in young children.
METHODS: Data from the Cincinnati Childhood Allergy and Air Pollution Study (n = 762) birth cohort were used to identify factors that predicted asthma development. The Pediatric Asthma Risk Score (PARS) was constructed by integrating demographic and clinical data. The sensitivity and specificity of PARS were compared with those of the Asthma Predictive Index (API) and replicated in the Isle of Wight birth cohort.
RESULTS: PARS reliably predicted asthma development in the Cincinnati Childhood Allergy and Air Pollution Study (sensitivity = 0.68, specificity = 0.77). Although both the PARS and API predicted asthma in high-risk children, the PARS had improved ability to predict asthma in children with mild-to-moderate asthma risk. In addition to parental asthma, eczema, and wheezing apart from colds, variables that predicted asthma in the PARS included early wheezing (odds ratio [OR], 2.88; 95% CI, 1.52-5.37), sensitization to 2 or more food allergens and/or aeroallergens (OR, 2.44; 95% CI, 1.49-4.05), and African American race (OR, 2.04; 95% CI, 1.19-3.47). The PARS was replicated in the Isle of Wight birth cohort (sensitivity = 0.67, specificity = 0.79), demonstrating that it is a robust, valid, and generalizable asthma predictive tool.
CONCLUSIONS: The PARS performed better than the API in children with mild-to-moderate asthma. This is significant because these children are the most common and most difficult to predict and might be the most amenable to prevention strategies.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma prediction score; childhood asthma; persistent wheezing; sensitization

Year:  2018        PMID: 30554722      PMCID: PMC6504569          DOI: 10.1016/j.jaci.2018.09.037

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  35 in total

1.  A clinical index to define risk of asthma in young children with recurrent wheezing.

Authors:  J A Castro-Rodríguez; C J Holberg; A L Wright; F D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

2.  High prevalence of aeroallergen sensitization among infants of atopic parents.

Authors:  Grace K LeMasters; Kimberly Wilson; Linda Levin; Jocelyn Biagini; Patrick Ryan; James E Lockey; Sherry Stanforth; Stephanie Maier; Jun Yang; Jeff Burkle; Manuel Villareal; Gurjit K Khurana Hershey; David I Bernstein
Journal:  J Pediatr       Date:  2006-10       Impact factor: 4.406

Review 3.  Genomic approaches to understanding asthma.

Authors:  L J Palmer; W O Cookson
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

4.  Mold exposure during infancy as a predictor of potential asthma development.

Authors:  Yulia Y Iossifova; Tiina Reponen; Patrick H Ryan; Linda Levin; David I Bernstein; James E Lockey; Gurjit K Khurana Hershey; Manuel Villareal; Grace LeMasters
Journal:  Ann Allergy Asthma Immunol       Date:  2009-02       Impact factor: 6.347

5.  Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma.

Authors:  Theresa W Guilbert; Wayne J Morgan; Robert S Zeiger; Leonard B Bacharier; Susan J Boehmer; Marzena Krawiec; Gary Larsen; Robert F Lemanske; Andrew Liu; David T Mauger; Chris Sorkness; Stanley J Szefler; Robert C Strunk; Lynn M Taussig; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

6.  Comparison of allergic indices in monosensitized and polysensitized patients with childhood asthma.

Authors:  Kyung Won Kim; Eun Ah Kim; Byoung Chul Kwon; Eun Soo Kim; Tae Won Song; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

7.  Characterization of wheezing phenotypes in the first 10 years of life.

Authors:  R J Kurukulaaratchy; M H Fenn; L M Waterhouse; S M Matthews; S T Holgate; S H Arshad
Journal:  Clin Exp Allergy       Date:  2003-05       Impact factor: 5.018

8.  Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age.

Authors:  C S Devulapalli; K C L Carlsen; G Håland; M C Munthe-Kaas; M Pettersen; P Mowinckel; K-H Carlsen
Journal:  Thorax       Date:  2007-07-05       Impact factor: 9.139

9.  Predicting persistent disease among children who wheeze during early life.

Authors:  R J Kurukulaaratchy; S Matthews; S T Holgate; S H Arshad
Journal:  Eur Respir J       Date:  2003-11       Impact factor: 16.671

10.  Early-life environmental risk factors for asthma: findings from the Children's Health Study.

Authors:  Muhammad Towhid Salam; Yu-Fen Li; Bryan Langholz; Frank Davis Gilliland
Journal:  Environ Health Perspect       Date:  2004-05       Impact factor: 9.031

View more
  16 in total

1.  Things We Do for No Reason: Systemic Corticosteroids for Wheezing in Preschool-Aged Children.

Authors:  Yemisi O Jones; Brittany B Hubbell; Joanna Thomson; Jennifer K O'Toole
Journal:  J Hosp Med       Date:  2019-07-24       Impact factor: 2.960

2.  Preschool Wheezing Phenotypes Exhibit Heterogeneity in Disease Expression and Prognosis.

Authors:  Leonard B Bacharier; Theresa W Guilbert
Journal:  Ann Am Thorac Soc       Date:  2019-07

3.  The pediatric asthma risk score (PARS): making the move to the most accurate pediatric asthma risk screening tool.

Authors:  Michael G Sherenian; Jocelyn M Biagini Myers; Lisa J Martin; Gurjit K Khurana Hershey
Journal:  Expert Rev Clin Immunol       Date:  2019-10-24       Impact factor: 4.473

4.  Longitudinal atopic dermatitis endotypes: An atopic march paradigm that includes Black children.

Authors:  Jocelyn M Biagini; John W Kroner; Asel Baatyrbek Kyzy; Alexandra Gonzales; Hua He; Mariana Stevens; Brittany Grashel; Daniel Spagna; Samuel Paul; Rahul Patel; Angelo Bucci; Michael G Sherenian; Liza Bronner Murrison; Lisa J Martin; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2021-10-18       Impact factor: 14.290

5.  The Pediatric Asthma Risk Score: More does not mean better.

Authors:  Missy MacDonald; Wan-Chi Chang; Lisa J Martin; Gurjit K Khurana Hershey; Jocelyn M Biagini
Journal:  Ann Allergy Asthma Immunol       Date:  2022-03-30       Impact factor: 6.248

6.  Use of the Pediatric Asthma Risk Score to predict allergic and nonallergic asthma.

Authors:  Eric Schauberger; Jocelyn M Biagini Myers; Hua He; Lisa J Martin; S Hasan Arshad; Ramesh Kurukulaaratchy; Gurjit K Khurana Hershey
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-20       Impact factor: 6.347

7.  Genetic ancestry differences in pediatric asthma readmission are mediated by socioenvironmental factors.

Authors:  Tesfaye B Mersha; Ke Qin; Andrew F Beck; Lili Ding; Bin Huang; Robert S Kahn
Journal:  J Allergy Clin Immunol       Date:  2021-07-01       Impact factor: 10.793

8.  Performance of Three Asthma Predictive Tools in a Cohort of Infants Hospitalized With Severe Bronchiolitis.

Authors:  Ronaldo C Fabiano Filho; Ruth J Geller; Ludmilla Candido Santos; Janice A Espinola; Lacey B Robinson; Kohei Hasegawa; Carlos A Camargo
Journal:  Front Allergy       Date:  2021-10-22

Review 9.  Asthma.

Authors:  Shilpa J Patel; Stephen J Teach
Journal:  Pediatr Rev       Date:  2019-11

Review 10.  Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm.

Authors:  Yadu Gautam; Elisabet Johansson; Tesfaye B Mersha
Journal:  J Pers Med       Date:  2022-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.